Superior Trunk Block Applied for Upper Arm and Shoulder Surgery
Primary Purpose
Post Operative Pain
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
superior trunk block
intravenous patient-controlled analgesia
Sponsored by
About this trial
This is an interventional treatment trial for Post Operative Pain
Eligibility Criteria
Inclusion Criteria:
- Patients who were in the American Society of Anesthesiologists (ASA) I-III class
- Underwent Shoulder surgery and upper arm surgery
Exclusion Criteria:
- Previous local anesthetic allergy,
- Having a bleeding diathesis disorder,
- Mental disorder,
- Allergic to the drugs used,
- Patients who did not consent to participate in the study,
- Presence of infection in the block area,
- Patients with a body mass index above 30
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
superior trunk block
tramadol
Arm Description
Ultrasound guided superior trunk block with 10 ml % 0.25 bupivacaine + 400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.
400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.
Outcomes
Primary Outcome Measures
Visual Analog Scale
Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)
Secondary Outcome Measures
tramadol consumption amount
tramadol consumption amount with patient-controlled analgesia device
additional analgesic use amount
The amount of paracetamol (intravenous, 1 g) or non-steroidal anti-inflammatory drug to be administered to patients with a Visuel analog scale above 5 after the operation.
Full Information
NCT ID
NCT05474014
First Posted
July 19, 2022
Last Updated
July 21, 2022
Sponsor
Bursa Yüksek İhtisas Education and Research Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05474014
Brief Title
Superior Trunk Block Applied for Upper Arm and Shoulder Surgery
Official Title
Investigation of the Effectiveness of Superior Trunk Block Applied for Upper Arm and Shoulder Surgery Operation Analgesia
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 20, 2022 (Anticipated)
Primary Completion Date
November 1, 2022 (Anticipated)
Study Completion Date
December 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bursa Yüksek İhtisas Education and Research Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Nerve blocks applied with ultrasonography are currently used for many post-operative pain and operations. Providing adequate area analgesia is the primary goal of clinicians, as early mobilization is suggested after shoulder and arm surgery.
In this study aimed to investigate the effect of superior trunk block application on postoperative analgesic and motor functions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post Operative Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
superior trunk block
Arm Type
Active Comparator
Arm Description
Ultrasound guided superior trunk block with 10 ml % 0.25 bupivacaine
+ 400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.
Arm Title
tramadol
Arm Type
Active Comparator
Arm Description
400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.
Intervention Type
Procedure
Intervention Name(s)
superior trunk block
Intervention Description
Local anesthetic injection will be applied to the superior trunk of the brachial plexus accompanied by ultrasonography.
Intervention Type
Drug
Intervention Name(s)
intravenous patient-controlled analgesia
Intervention Description
Analgesics will be given using a patient-controlled analgesia device.
Primary Outcome Measure Information:
Title
Visual Analog Scale
Description
Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)
Time Frame
Postoperative 24 hours
Secondary Outcome Measure Information:
Title
tramadol consumption amount
Description
tramadol consumption amount with patient-controlled analgesia device
Time Frame
Postoperative 24 hours
Title
additional analgesic use amount
Description
The amount of paracetamol (intravenous, 1 g) or non-steroidal anti-inflammatory drug to be administered to patients with a Visuel analog scale above 5 after the operation.
Time Frame
Postoperative 24 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who were in the American Society of Anesthesiologists (ASA) I-III class
Underwent Shoulder surgery and upper arm surgery
Exclusion Criteria:
Previous local anesthetic allergy,
Having a bleeding diathesis disorder,
Mental disorder,
Allergic to the drugs used,
Patients who did not consent to participate in the study,
Presence of infection in the block area,
Patients with a body mass index above 30
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Korgün Ökmen, Assoc. PhD.
Phone
+905057081021
Email
korgunokmen@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Korgün Ökmen, Assoc. PhD.
Organizational Affiliation
Sağlık Bilimleri Üniversitesi Bursa Yüksek İhtisas Eğitim Ve Araştırma Hastanesi
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Superior Trunk Block Applied for Upper Arm and Shoulder Surgery
We'll reach out to this number within 24 hrs